Naldemedine phase 3 study shows significant improvement for patients with Opioid-Induced Constipation
22 Feb 2016
16.02.2016 Naldemedine Phase3 Study Shows Significant Improv
© Shionogi B.V. 2020. All rights reserved. This website is owned by Shionogi B.V. Registered with the Trade Register of the Dutch Chamber of Commerce under number 73229180. Registered address is Kingsfordweg 151, 1043GR, Amsterdam, the Netherlands.
Report Side Effect
Just to let you know, you are now moving to another website this is not under our control and Shionogi Limited is not responsible for its contents.